ALSO NOTED: OxiGene touts data; Caraco wins FDA nod; SuperGen cited for leukemia ads; and much more...

> OxiGene is touting new clinical data for its lead vascular disruption agent. Release

> Detroit-based Caraco Pharmaceutical Laboratories has received the FDA's approval of an ANDA for Zolpidem Tartrate, 5mg and 10mg tablets. Release

> Dublin, California-based SuperGen has been cited by the FDA for what it calls misleading ads about SuperGen's Nipent leukemia drug. Story

> India's Biocon will collaborate with Nobex on a new oral peptide therapy for cardiovascular disease. Report

> A federal judge has dismissed a class-action suit against Saddle River, New Jersey-based PDI. Release

> The FDA has cleared a new pharmacogenetic test from Third Wave Technologies of Madison, Wisconsin. Release

And Finally… The Washington Post examines the 40-year career of Robert Webster, who's pioneering work on avian flu continues to play a key role in fighting against an outbreak of a global pandemic. Article